Larvol Delta - Phase-12a-Ascending-Dose-Study-to-Evaluate-the-Safety-BSB1001-in-Patients-Undergoing-HLAMatched-Allogenic-Hematopoietic-Stem-Cell-Transplant-for-AML-ALL-or-MDS

BSB-1001 - BlueSphere Bio

melphalan - Generic mfg.

http://clinicaltrials.gov/ct2/show/NCT06704152

Nov 25, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next